A Promising Therapeutic Approach for Multiple Sclerosis: Recombinant T-Cell Receptor Ligands Modulate Experimental Autoimmune Encephalomyelitis by Reducing Interleukin-17 Production and Inhibiting Migration of Encephalitogenic Cells into the CNS

Recombinant T-cell receptor ligands (RTLs) can prevent and reverse clinical and histological signs of experimental autoimmune encephalomyelitis (EAE) in an antigen-specific manner and are currently in clinical trials for treatment of subjects with multiple sclerosis (MS). To evaluate regulatory mech...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Neurosci
Main Authors: Sinha, Sushmita, Subramanian, Sandhya, Proctor, Thomas M., Kaler, Laurie J., Grafe, Marjorie, Dahan, Rony, Huan, Jianya, Vandenbark, Arthur A., Burrows, Gregory G., Offner, Halina
Formato: Artigo
Idioma:Inglês
Publicado em: Society for Neuroscience 2007
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6673319/
https://ncbi.nlm.nih.gov/pubmed/18003831
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1523/JNEUROSCI.3599-07.2007
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados